UChicago Medicine secures approval to design $633M cancer center

University of Chicago Medicine received approval from the Illinois Health Facilities and Services Review Board to begin designing and planning the state’s first freestanding cancer center, which will cost $633 million.

Advertisement

If the project receives regulatory approval, construction will begin in 2023 and the center will open in 2026, according to a March 15 UChicago news release.

The project will span 500,000 square feet on the city’s South Side. It will add 128 beds, which will be dedicated to patients with cancer, to the hospital’s campus, freeing other beds for patients with complex and acute care needs.

The cancer center will also address healthcare inequities for residents of the city’s South Side, who have a higher cancer burden and less access to care, UChicago said.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Capital

Advertisement

Comments are closed.